We are live on ! Find out more
NCM

Narwhal Capital Management Portfolio holdings

AUM $1.45B
1-Year Est. Return 28.39%
This Fund
S&P 500
This Quarter Est. Return
+5.25%
1 Year Est. Return
+28.39%
3 Year Est. Return
+93.85%
5 Year Est. Return
+119.75%
10 Year Est. Return
+391.36%
AUM
$435M
AUM Growth
+$31.6M
Cap. Flow
+$12.6M
Cap. Flow %
2.89%
Top 10 Hldgs %
28.37%
Holding
157
New
10
Increased
69
Reduced
42
Closed
10

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$2.63M
2
ABT icon
Abbott
ABT
+$2.55M
3
JCI icon
Johnson Controls International
JCI
+$1.93M
4
AAPL icon
Apple
AAPL
+$1.7M
5
PG icon
Procter & Gamble
PG
+$1.49M

Top Sells

Rank Stock Value
1
VMC icon
Vulcan Materials
VMC
+$9.94M
2
CVS icon
CVS Health
CVS
+$1.86M
3
HCA icon
HCA Healthcare
HCA
+$1.76M
4
DIS icon
Walt Disney
DIS
+$1.69M
5
CELG
Celgene Corp
CELG
+$1.29M

Sector Composition

Rank Sector Weight
1 Technology 14.1%
2 Financials 12.7%
3 Healthcare 10.25%
4 Industrials 9.4%
5 Communication Services 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NKE icon
151
Nike
NKE
$61.9B
-10,375
Closed -$538K
VCR icon
152
Vanguard Consumer Discretionary ETF
VCR
$6.33B
-2,303
Closed -$330K
VNQ icon
153
Vanguard Real Estate ETF
VNQ
$39B
-2,580
Closed -$214K
VPU
154
Vanguard Utilities ETF
VPU
$8.36B
-2,579
Closed -$301K
VTI icon
155
Vanguard Morningstar Total Stock Market ETF
VTI
$684B
-2,350
Closed -$304K
VV icon
156
Vanguard Morningstar Large-Cap ETF
VV
$54.3B
-2,778
Closed -$321K
CELG
157
DELISTED
Celgene Corp
CELG
-8,840
Closed -$1.29M

Similar funds

Narwhal Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Narwhal Capital Management held 157 positions worth $435M, up 7.8% from $403M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Narwhal Capital Management's Q4 2017 filing shows 10 new, 69 increased, 42 reduced and 10 closed positions. Its largest new stake was Abbott: 45,967 shares worth $2.62M. The largest sale was Vulcan Materials, an estimated $9.94M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • Narwhal Capital Management's largest Q4 2017 buy was Abbott: 45,967 shares worth $2.62M.
  • Narwhal Capital Management added most to UnitedHealth in Q4 2017, an estimated $2.63M increase.
  • Narwhal Capital Management's biggest Q4 2017 reduction was Vulcan Materials, cutting an estimated $9.94M.
  • Narwhal Capital Management fully exited Celgene Corp in Q4 2017, selling an estimated $1.29M.
  • Narwhal Capital Management's ten largest holdings make up 28% of its $435M portfolio in Q4 2017.
  • Narwhal Capital Management opened 10 new positions and closed 10 in Q4 2017.
  • Narwhal Capital Management's portfolio value rose 7.8% quarter-over-quarter to $435M.

Based on Narwhal Capital Management's 13F filing for Q4 2017, filed 23 Jan 2018.